Although a pharmacological experiment in 3-month-old APP/PS1-Tg mice does include a survival bias, our preliminary data, to the contrary, showed an apparent trend on the improvement in working memory (Supplementary Fig.
← all excerpts
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice.
1
—
—